Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Nov 11;2015(11):CD000491.
doi: 10.1002/14651858.CD000491.pub3.

Duration of treatment for asymptomatic bacteriuria during pregnancy

Mariana Widmer  1 , Ivana Lopez, A Metin Gülmezoglu, Luciano Mignini, Ariel Roganti
Affiliations
Meta-Analysis

Duration of treatment for asymptomatic bacteriuria during pregnancy

Mariana Widmer et al. Cochrane Database Syst Rev. .

Abstract

Background: A previous Cochrane systematic review has shown that antibiotic drug treatment of asymptomatic bacteriuria in pregnant women substantially decreases the risk of pyelonephritis and reduces the risk of preterm delivery. However, it is not clear whether single-dose therapy is as effective as longer conventional antibiotic treatment.

Objectives: To assess the effects of different durations of treatment for asymptomatic bacteriuria in pregnancy.

Search methods: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 August 2015) and reference lists of identified articles.

Selection criteria: Randomized and quasi-randomized trials comparing antimicrobial therapeutic regimens that differed in duration (particularly comparing single dose with longer duration regimens) in pregnant women diagnosed with asymptomatic bacteriuria.

Data collection and analysis: Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. We assessed the quality of the evidence using the GRADE approach.

Main results: We included 13 studies, involving 1622 women. All were comparisons of single-dose treatment with short-course (four- to seven-day) treatments. The risk of bias of trials included in this review was largely unclear, and most trials were at high risk of performance bias. The quality of the evidence was assessed using the GRADE approach. When the any antibiotic agent was used, the 'no cure' rate for asymptomatic bacteriuria in pregnant women was slightly lower for the short-course treatment over the single-dose treatment, although there was evidence of statistical heterogeneity (average risk ratio (RR) 1.28, 95% confidence interval (CI) 0.87 to 1.88; women = 1502, studies = 13; I² = 56%; very low quality evidence). Data from only good quality trials also showed better cure rates with short (four- to seven-day) regimens of the same microbial agent (average RR 1.72, 95% CI 1.27 to 2.33; women = 803, studies = two; I² = 0%; high quality evidence). There was no clear difference in the recurrence of asymptomatic bacteriuria rate between treatment and control groups, whether the same or different microbial agents were used (RR 1.13, 95% CI 0.77 to 1.66; 445 women studies = eight; I² = 0%; very low quality evidence). Differences were detected for low birthweight babies, favoring a short course (four- to seven-day treatment) of the same microbial agent, although the data come from a single trial (RR 1.65, 95% CI 1.06 to 2.57; 714 women; high quality evidence), but no differences were observed for preterm delivery (RR 1.17, 95% CI 0.77 to 1.78; women = 804; studies = three; I² = 23%; moderate quality) or pyelonephritis (RR 3.09, 95% CI 0.54 to 17.55; women = 102; studies = two; I² = 0%; very low quality evidence). Finally, single-dose treatment of any microbial agent was associated with a decrease in reports of 'any side effects' (RR 0.70, 95% CI 0.56 to 0.88; 1460 women, studies = 12; I² = 9%; low quality evidence). Evidence was downgraded for risk of bias concerns in trials contributing data and for imprecise effect estimates (wide confidence intervals crossing the line of no effect, and in some cases, small studies with few events).

Authors' conclusions: A single-dose regimen of antibiotics may be less effective than a short-course (four- to seven-day) regimen, but more evidence is needed from large trials measuring important outcomes, such as cure rate. Women with asymptomatic bacteriuria in pregnancy should be treated by the standard regimen of antibiotics until more data become available testing seven-day treatment compared with shorter courses of three- or five-day regimens.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
3
3
Funnel plot of comparison: 1 Single dose versus short‐course (4‐7 day) antibiotic for asymptomatic bacteriuria, outcome: 1.6 No cure.
1.1
1.1. Analysis
Comparison 1 Single dose versus short‐course (4‐7 day) antibiotic for asymptomatic bacteriuria, Outcome 1 No cure.
1.2
1.2. Analysis
Comparison 1 Single dose versus short‐course (4‐7 day) antibiotic for asymptomatic bacteriuria, Outcome 2 Recurrent asymptomatic bacteriuria.
1.3
1.3. Analysis
Comparison 1 Single dose versus short‐course (4‐7 day) antibiotic for asymptomatic bacteriuria, Outcome 3 Pyelonephritis.
1.4
1.4. Analysis
Comparison 1 Single dose versus short‐course (4‐7 day) antibiotic for asymptomatic bacteriuria, Outcome 4 Preterm delivery.
1.5
1.5. Analysis
Comparison 1 Single dose versus short‐course (4‐7 day) antibiotic for asymptomatic bacteriuria, Outcome 5 Low birthweight.
1.6
1.6. Analysis
Comparison 1 Single dose versus short‐course (4‐7 day) antibiotic for asymptomatic bacteriuria, Outcome 6 Side effects.
2.1
2.1. Analysis
Comparison 2 Single dose versus short‐course (4‐7 day) antibiotic for asymptomatic bacteriuria (subgrouped by trial quality), Outcome 1 Same antimicrobial agent.
2.2
2.2. Analysis
Comparison 2 Single dose versus short‐course (4‐7 day) antibiotic for asymptomatic bacteriuria (subgrouped by trial quality), Outcome 2 Different antimicrobial agents.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Anderton 1983 {published data only}
    1. Anderton KJ, Abbas AM, Davey A, Ancill RJ. High dose, short course amoxycillin in the treatment of bacteriuria in pregnancy. British Journal of Clinical Practice 1983;37:212‐4. - PubMed
Bailey 1983 {published data only}
    1. Bailey RR, Bishop V, Peddie BA. Comparison of single dose with a 5‐day course of co‐trimoxazole for asymptomatic (covert) bacteriuria of pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 1983;23:139‐41. - PubMed
Bailey 1986 {published data only}
    1. Bailey RR, Peddie BA, Bishop V. Comparison of single dose with a 5‐day course of trimethoprim for asymptomatic (covert) bacteriuria of pregnancy. New Zealand Medical Journal 1986;99:501‐3. - PubMed
Bayrak 2007 {published data only}
    1. Bayrak O, Cimentepe E, Inegol I, Atmaca AF, Duvan CI, Koc A, et al. Is single‐dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimester of pregnancy?. International Urogynecology Journal 2007;18(5):525‐9. - PubMed
Brumfitt 1982 {published data only}
    1. Brumfitt W, Hamilton Miller JM, Franklin IN, Anderson FM, Brown GM. Conventional and two dose amoxycillin treatment of bacteriuria in pregnancy and recurrent bacteriuria: a comparative study. Journal of Antimicrobial Chemotherapy 1982;10:239‐48. - PubMed
Estebanez 2009 {published data only}
    1. Estebanez A, Pascual R, Gil V, Ortiz F, Santibanez M, Perez Barba C. Fosfomycin in a single dose versus a 7‐day course of amoxicillin‐clavulanate for the treatment of asymptomatic bacteriuria during pregnancy. European Journal of Clinical Microbiology & Infectious Diseases 2009;28(12):1457‐64. - PubMed
Gerstner 87‐89 {published data only}
    1. Gerstner GJ, Muller G, Nahler G. Amoxicillin in the treatment of asymptomatic bacteriuria in pregnancy: a single dose of 3g amoxicillin vs a 4‐day course of 3 doses 750mg amoxicillin. Gynecologic and Obstetric Investigation 1989;27:84‐7. - PubMed
    1. Gertsner GJ, Muller G, Nahler G. Amoxicillin in the treatment of asymptomatic bacteriuria in pregnancy‐‐3g single dose versus 3 times 750mg 4‐day therapy [Amoxicillin zur Behandlung der asymptomatischen Bakteriurie in der Schwangerschaft‐‐3g Einmal‐versus 3 x 750mg 4‐Tagestherapie]. Zeitschrift fur Geburtshilfe und Perinatologie 1987;191(5):202‐5. - PubMed
Lumbiganon 2009 {published data only}
    1. Lumbiganon P, Villar J, Laopaiboon M, Widmer M, Thinkhamrop J, Carroli G, et al. One‐day compared with 7‐day nitrofurantoin for asymptomatic bacteriuria in pregnancy: a randomized controlled trial. Obstetrics & Gynecology 2009;113(2 Pt 1):339‐45. - PubMed
    1. World Health Organization. Multicentre randomized placebo‐controlled trial to evaluate the effectiveness of one‐day versus seven‐day course of nitrofurantoin for the treatment of asymptomatic bacteriuria. World Health Organization (www.who.int/reproductive‐health/publications/highlights/hights_hrp_2005....) (accessed 25 April 2006).
Masterton 1985 {published data only}
    1. Masterton RG, Evans DC, Strike PW. Single‐dose amoxycillin in the treatment of bacteriuria in pregnancy and the puerperium‐a controlled clinical trial. British Journal of Obstetrics and Gynaecology 1985;92:498‐505. - PubMed
Olsen 1989 {published data only}
    1. Olsen L, Nielsen IK, Zachariassen A, Sederberg‐Olsen J, Frimodt‐Moller N. Single‐dose vs six‐day therapy with sulfamethizole for asymptomatic bacteriuria during pregnancy. Danish Medical Bulletin 1989;36:486‐7. - PubMed
Pregazzi 1987 {published data only}
    1. Pregazzi R, Mazzatenta E, Bouche C. Single‐dose antibiotic therapy of asymptomatic bacteriuria in pregnancy. Results and complications. Minerva Ginecologica 1987;39:289‐92. - PubMed
Reeves 1975 {published data only}
    1. Reeves DS. Laboratory and clinical studies with sulfametopyrazine as a treatment for bacteriuria in pregnancy. Journal of Antimicrobial Chemotherapy 1975;1:171‐86. - PubMed
Thoumsin 1990 {published data only}
    1. Thoumsin H, Aghayan M, Lambotte R. Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results. Infection 1990;18:S94‐7. - PubMed

References to studies excluded from this review

Adelson 1992 {published data only}
    1. Adelson MD, Graves WL, Osborne NG. Treatment of urinary infections in pregnancy using single dose vs 10 day dosing. Journal of the National Medical Association 1992;84:73‐5. - PMC - PubMed
Bint 1979 {published data only}
    1. Bint A, Bullock D, Reeves D, Wilkinson P. A comparative trial of pivmecillinam and ampicillin in bacteriuria in pregnancy. Infection 1979;7:290‐3. - PubMed
Brumfitt 1973 {published data only}
    1. Brumfitt W, Pursell R. Trimethoprim ‐ sulfamethoxazole in treatment of bacteriuria in women. Journal of Infectious Diseases 1973;128 Suppl:S657‐S663. - PubMed
Campbell‐Brown 1983 {published data only}
    1. Campbell‐Brown M, Fadyen IR. Bacteriuria in pregnancy treated with a single dose of cephalexin. British Journal of Obstetrics and Gynaecology 1983;90(11):1054‐9. - PubMed
Davies 1975 {published data only}
    1. Davies BI, Mummery RV, Brummfitt W. Ampicillin, carbenicillin indanyl ester, and nifurantel in treatment of urinary infection in domiciliary practice. British Journal of Urology 1975;47:335‐41. - PubMed
De Cecco 1987 {published data only}
    1. Cecco L, Ragni N. Urinary tract infections in pregnancy: monuril single‐dose treatment vs traditional therapy. European Urology 1987;13:108‐13. - PubMed
Harris 1982 {published data only}
    1. Harris RE, Gilstrap LC, Pretty A. Single‐dose antimicrobial therapy for asymptomatic bacteriuria during pregnancy. Obstetrics & Gynecology 1982;59:546‐8. - PubMed
Jakobi 1987 {published data only}
    1. Jakobi P, Neiger R, Merzbach D, Paldi E. Single‐dose antimicrobial therapy in the treatment of asymptomatic bacteriuria in pregnancy. American Journal of Obstetrics and Gynecology 1987;156(5):1148‐52. - PubMed
McFadyen 1987 {published data only}
    1. McFadyen IR, Campbell BM, Stephenson M, Seal DV. Single‐dose treatment of bacteriuria in pregnancy. European Urology 1987;13 Suppl 1:22‐5. - PubMed
Pathak 1969 {published data only}
    1. Pathak UN, Tang K, Williams LL, Stuart KL. Bacteriuria of pregnancy: results of treatment. Journal of Infectious Diseases 1969;120:91‐103. - PubMed
Pedler 1985 {published data only}
    1. Pedler S, Bint A. Comparative study of amoxicillin‐clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy. Antimicrobial Agents and Chemotherapy 1985;27:508‐10. - PMC - PubMed
Rafalsky 2013 {published data only}
    1. Rafal'skii VV, Dovgan' EV, Kozyrev IuV, Gustovarova TA, Khlybova SV, Novoselova AV, et al. The efficacy and safety of cefixime and amoxicillin/clavulanate in the treatment of asymptomatic bacteriuria in pregnant women: a randomized, prospective, multicenter study. Urologiia 2013;5(24):26‐8. - PubMed
    1. Rafalskiy V, Dovgan E, Kozyrev Y, Gustovarova T, Khlybova S, Novoselova A, et al. Cefixime vs. amoxicillin/clavulanate in pregnant women with asymptomatic bacteriuria: Multicentre randomised study. Clinical Microbiology and Infection 2012;18(Suppl s3):425‐6.
Robertson 1968 {published data only}
    1. Robertson JG, Livingstone JRB, Isdale MH. The management and complications of asymptomatic bacteriuria in pregnancy. Journal of Obstetrics and Gynaecology of the British Commonwealth 1968;75:59‐65. - PubMed
Sanderson 1984 {published data only}
    1. Sanderson P, Menday P. Pivmecillinam for bacteriuria in pregnancy. Journal of Antimicrobial Chemotherapy 1984;13:383‐8. - PubMed
Whalley 1977 {published data only}
    1. Whalley PJ, Cunningham FG. Short‐term vs continuous antimicrobial therapy for asymptomatic bacteriuria in pregnancy. Obstetrics & Gynecology 1977;49:262‐5. - PubMed
Zinner 1990 {published data only}
    1. Zinner S. Fosfomycin trometamol versus pipemidic acid in the treatment of bacteriuria during pregnancy. Chemotherapy 1990;36:50‐2. - PubMed

Additional references

Andrews 1992
    1. Andrews WW, Gilstrap LC. Urinary tract infections. In: Gleicher N editor(s). Principles and Practice of Medical Therapies in Pregnancy. Appleton and Lange, Norwalk, Co, 1992:913‐7.
Davison 1992
    1. Davison JM, Lindheimer MD. Chronic renal disease. In: Gleicher N editor(s). Principles and Practice of Medical Therapies in Pregnancy. Appleton and Lange, Norwalk, Co, 1992:928‐32.
Goldenberg 2000
    1. Goldberg RL, Hauth JC, Andrews WW. Mechanisms of disease: intrauterine infection and preterm delivery. New England Journal of Medicine 2000;342(20):1500‐7. - PubMed
Higgins 2011
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Jones 1996
    1. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996;313:36‐9. - PMC - PubMed
Kazemier 2015
    1. Kazemier BM, Koningstein FN, Schneeberger C, Ott A, Bossuyt PM, Miranda E, et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infectious Diseases 2015 August. [Epub ahead of print]. - PubMed
Laxminarayan 2014
    1. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance ‐ the need for global solutions. Lancet Infectious Diseases 2013;13(2):1057‐98. - PubMed
Meis 1995a
    1. Meis PJ, Michielutte R, Peters TJ, Wells HB, Sands E, Coles EC, et al. Factors associated with preterm birth in Cardiff, Wales. I. Univariable and multivariable analysis. American Journal of Obstetrics and Gynecology 1995;173:590‐6. - PubMed
Meis 1995b
    1. Meis PJ, Michielutte R, Peters TJ, Wells HB, Sands E, Coles EC, et al. Factors associated with preterm birth in Cardiff, Wales. II. Indicated and spontaneous preterm birth. American Journal of Obstetrics and Gynecology 1995;173:597‐602. - PubMed
NICE 2008
    1. National Institute for Health and Clinical Excellence: Guidance. In: Jane Moody editor(s). Antenatal Care: Routine Care for the Healthy Pregnant Woman. London: RCOG Press, 2008. - PubMed
Nicolle 2005
    1. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clinical Infectious Diseases 2005;40(5):643‐54. - PubMed
NVOG 2011
    1. Dutch Society of Obstetrics and Gynecology. NVOG Guideline: Urinary Tract Infection in Pregnancy. Amsterdam: NVOG, 2011.
Ramsey 2000
    1. Ramsey P, Goldenberg R. Maternal Infections and their consequences. In: Newell, McIntyre editor(s). Congenital and Perinatal Infections. Prevention, Diagnosis and Treatment. 1st Edition. Cambridge: Cambridge University Press, 2000:32‐63.
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Romero 1989
    1. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta‐analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstetrics & Gynecology 1989;73:576‐82. - PubMed
Rouse 1995
    1. Rouse DJ, Andrews WW, Goldenberg RL, Owen J. Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost‐effectiveness and cost‐beneficial analysis. Obstetrics & Gynecology 1995;86:119‐23. - PubMed
Smaill 2015
    1. Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews 2015, Issue 8. [DOI: 10.1002/14651858.CD000490.pub3] - DOI - PubMed
Sweet 1977
    1. Sweet RL. Bacteriuria and pyelonephritis during pregnancy. Seminars in Perinatology 1977;1:25‐40. - PubMed
Van Haaren 2005
    1. Haaren KAM, Visser HS, Vliet S, Timmermans AE, Yadava R, Geerlings SE, et al. Guideline of the Dutch College of General Practitioners on urinary tract infections: second revision [NHG‐standaard urineweginfecties: 2e herziening]. Huisarts en Wetenschap 2005;48(10):341‐52.
Villar 1994
    1. Villar J, Ezcurra EJ, Gurtner de la Fuente V, Campodonico L. Preterm delivery syndrome ‐ the unmet need. Research and Clinical Forums 1994;16:9‐39.
Villar 1997
    1. Villar J, Gülmezoglu AM, Onis M. Nutritional and antimicrobial interventions to prevent preterm birth: an overview of randomized control trials. Obstetrical & Gynecological Survey 1998;53:575‐85. - PubMed
Wang 1989
    1. Wang E, Smaill F. Infection in pregnancy. In: Chalmers I, Enkin MW, Keirse MJNC editor(s). Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1989:534‐7.

References to other published versions of this review

Smaill 1992a
    1. Smaill F. Single dose vs 4‐7 day antibiotic for bacteriuria. [revised 02 April 1992]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
Smaill 1992b
    1. Smaill F. Single dose vs 7‐day course of antibiotics for bacteriuria. [revised 02 April 1992]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration. Issue 2, Oxford: Update Software; 1995.
Smaill 1992c
    1. Smaill F. Two week vs continuous antibiotic for bacteriuria. [revised 02 April 1992]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration. Issue 2, Oxford: Update Software; 1995.
Villar 2000
    1. Villar J, Widmer M, Lydon‐Rochelle M, Gülmezoglu AM, Roganti A. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD000491] - DOI - PubMed
Widmer 2011
    1. Widmer M, Gülmezoglu AM, Mignini L, Roganti A. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD000491.pub2] - DOI - PubMed

Publication types

MeSH terms

Substances